Clinical trial
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage…
NCT00077311 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00077311 |
|---|---|
| Title | Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Official title | A Phase II Randomized Study Of Dose-Dense Docetaxel And Cisplatin Every Two Weeks With Pegfilgrastim And Darbepoetin Alfa With And Without The Chemoprotector BNP7787 In Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia |
| Intervention type | Biological, Drug |
| Interventions | darbepoetin alfa, pegfilgrastim, cisplatin, docetaxel, BNP7787 |
| Enrollment | 160 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Apr 1, 2009 |
| First posted | Feb 12, 2004 |
| Last update posted | Jun 30, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: